ERG SPA financials
ERG SPA
Country: IT Reporting currency: EUR Latest annual report: 2024-12-31
LEI:
8156004604684CA44A90 ISIN: IT0001157020 Financial statements
(EUR, as reported — unscaled; 126 line items across 2 annual periods)
| Line item | 2024 | 2023 |
|---|---|---|
| Income statement | ||
| Revenue | €738.1M | €740.9M |
| Other income | €55.2M | €26.2M |
| Employee benefits expense | €57.9M | €52.8M |
| Depreciation & amortisation | €77.6M | €67.8M |
| Operating profit (EBIT) | €252.6M | €304.2M |
| Net finance income / (cost) | -€27.2M | -€19.4M |
| Finance costs | €108.9M | €217.2M |
| Profit before tax | €223.4M | €290.1M |
| Income tax expense | €33.7M | €74.1M |
| Profit for the year | €189.7M | €180.5M |
| — attributable to owners | €187.1M | €178.7M |
| — attributable to NCI | €2.6M | €1.8M |
| Total comprehensive income | €201.8M | €298.2M |
| Cash flow statement | ||
| Net cash from operating activities | €484.2M | €882.5M |
| Income taxes paid | €39.4M | €25.5M |
| Net cash from investing activities | -€707.1M | -€316.5M |
| Purchase of PP&E (capex) | €228.1M | €300.1M |
| Purchase of intangibles | €5.9M | €5.7M |
| Net cash from financing activities | €356.4M | -€491.2M |
| Dividends paid | €152.1M | €154.0M |
| Lease liability payments | €17.6M | €13.8M |
| Balance sheet | ||
| Total assets | €6.32B | €5.21B |
| Non-current assets | €4.99B | €4.14B |
| Property, plant & equipment | €2.99B | €2.40B |
| Right-of-use assets | €218.0M | €165.9M |
| Intangible assets & goodwill | €454.0M | €412.5M |
| Current assets | €1.33B | €1.07B |
| Inventories | €23.4M | €20.0M |
| Trade & other receivables | €134.3M | €157.9M |
| Cash & equivalents | €601.0M | €467.6M |
| Total equity | €2.22B | €2.14B |
| — attributable to owners | €2.15B | €2.13B |
| Non-controlling interests | €76.5M | €6.7M |
| Non-current liabilities | €3.11B | €2.63B |
| Lease liabilities (non-current) | €222.9M | €165.7M |
| Current liabilities | €983.4M | €444.6M |
| Lease liabilities (current) | €6.5M | €6.4M |
| Deferred tax liabilities | €219.0M | €192.0M |
| Derived metrics | ||
| Free cash flow | €256.1M | €582.4M |
| Operating margin | 34.2% | 41.1% |
| Net margin | 25.7% | 24.4% |
| Return on equity | 8.5% | 8.4% |
| Cash conversion ratio | 2.55× | 4.89× |
| Capex coverage | 2.12× | 2.94× |
| Other reported items | ||
| Adjustments For Decrease Increase In Inventories | -€3.3M | -€2.3M |
| Adjustments For Decrease Increase In Trade Account Receivable | €27.0M | €53.4M |
| Adjustments For Finance Costs | €27.2M | €19.4M |
| Adjustments For Gains Losses On Change In Fair Value of Derivatives | €907.0K | -€152.9M |
| Adjustments For Income Tax Expense | €33.7M | €74.1M |
| Adjustments For Increase Decrease In Employee Benefit Liabilities | -€829.0K | -€180.0K |
| Adjustments For Increase Decrease In Trade Account Payable | -€7.3M | -€4.7M |
| Adjustments For Undistributed Profits of Investments Accounted For Using Equity Method | -€2.0M | €5.4M |
| Basic Earnings Loss Per Share From Continuing Operations | €1.30 | €1.45 |
| Basic Earnings Loss Per Share From Discontinued Operations | €0.00 | €-0.24 |
| Cash Flows From Losing Control of Subsidiaries Or Other Businesses Classified As Investing Activities | €0 | €5.5M |
| Cash Flows From Used In Financing Activities Continuing Operations | €356.4M | -€291.4M |
| Cash Flows From Used In Financing Activities Discontinued Operations | €0 | €199.8M |
| Cash Flows From Used In Increase Decrease In Current Borrowings | €26.9M | €84.5M |
| Cash Flows From Used In Investing Activities Continuing Operations | -€707.1M | -€313.8M |
| Cash Flows From Used In Investing Activities Discontinued Operations | €0 | €2.7M |
| Cash Flows From Used In Operating Activities Continuing Operations | €484.2M | €680.0M |
| Cash Flows From Used In Operating Activities Discontinued Operations | €0 | -€202.5M |
| Cash Flows From Used In Operations Before Changes In Working Capital | €518.7M | €512.4M |
| Cash Flows Used In Obtaining Control of Subsidiaries Or Other Businesses Classified As Investing Activities | €250.9M | €84.7M |
| Comprehensive Income Attributable To Noncontrolling Interests | €2.6M | €1.8M |
| Comprehensive Income Attributable To Owners of Parent | €199.2M | €296.3M |
| Current Financial Assets At Fair Value Through Profit Or Loss | €15.2M | €46.8M |
| Current Financial Liabilities At Fair Value Through Profit Or Loss | €9.8M | €5.9M |
| Current Tax Assets Current | €25.0M | €34.7M |
| Current Tax Liabilities Current | €35.4M | €40.2M |
| Deferred Tax Assets | €54.3M | €41.4M |
| Depreciation Expense | €189.2M | €157.1M |
| Diluted Earnings Loss Per Share From Continuing Operations | €1.30 | €1.45 |
| Dividends Recognised As Distributions To Owners Per Share | €1.00 | — |
| Equity and Liabilities | €6.32B | €5.21B |
| Finance Income | €81.7M | €197.8M |
| Income Tax Relating To Cash Flow Hedges of Other Comprehensive Income | -€1.1M | €39.5M |
| Income Tax Relating To Exchange Differences On Translation of Other Comprehensive Income | €3.9M | €4.8M |
| Income Tax Relating To Remeasurements of Defined Benefit Plans of Other Comprehensive Income | €46.0K | €22.0K |
| Increase Decrease In Cash and Cash Equivalents | €133.4M | €74.8M |
| Increase Decrease Through Acquisition of Subsidiary | €72.8M | — |
| Increase Decrease Through Appropriation of Retained Earnings | €0 | €0 |
| Increase Decrease Through Sharebased Payment Transactions | €4.4M | -€61.4M |
| Increase Decrease Through Transfers and Other Changes Equity | €3.7M | -€435.0K |
| Increase Decrease Through Treasury Share Transactions | €0 | — |
| Interest Paid Classified As Financing Activities | €15.9M | €9.4M |
| Investment Accounted For Using Equity Method | €428.0K | €1.1M |
| Issued Capital | €15.0M | €15.0M |
| Liabilities | €4.09B | €3.07B |
| Longterm Miscellaneous Other Provisions | €36.5M | €36.6M |
| Longterm Provision For Decommissioning Restoration and Rehabilitation Costs | €90.6M | €78.8M |
| Noncurrent Financial Assets At Fair Value Through Profit Or Loss | €36.0M | €34.1M |
| Noncurrent Financial Liabilities At Fair Value Through Profit Or Loss | €99.1M | €5.8M |
| Noncurrent Investments Other Than Investments Accounted For Using Equity Method | €805.0K | €1.6M |
| Noncurrent Provisions For Employee Benefits | €2.7M | €3.5M |
| Other Adjustments For Noncash Items | €3.2M | €30.1M |
| Other Comprehensive Income | €12.1M | €117.7M |
| Other Comprehensive Income Before Tax Cash Flow Hedges | -€4.1M | €136.6M |
| Other Comprehensive Income Before Tax Exchange Differences On Translation | €18.8M | €25.3M |
| Other Comprehensive Income Before Tax Gains Losses On Remeasurements of Defined Benefit Plans | €165.0K | €78.0K |
| Other Comprehensive Income Net of Tax Cash Flow Hedges | -€2.9M | €97.1M |
| Other Comprehensive Income Net of Tax Exchange Differences On Translation | €14.9M | €20.5M |
| Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss Net of Tax | €119.0K | €56.0K |
| Other Current Financial Assets | €452.3M | €241.7M |
| Other Current Financial Liabilities | €725.3M | €186.2M |
| Other Current Nonfinancial Assets | €80.7M | €100.0M |
| Other Current Nonfinancial Liabilities | €53.5M | €47.0M |
| Other Intangible Assets | €17.6M | €15.8M |
| Other Noncurrent Financial Assets | €48.2M | €48.0M |
| Other Noncurrent Financial Liabilities | €2.14B | €2.02B |
| Other Noncurrent Nonfinancial Assets | €54.2M | €45.2M |
| Other Noncurrent Nonfinancial Liabilities | €56.6M | €44.6M |
| Other Reserves | €1.69B | €1.64B |
| Payments To Acquire Or Redeem Entitys Shares | €47.3M | €61.4M |
| Proceeds From Disposals of Property Plant and Equipment Intangible Assets Other Than Goodwill Investment Property and Other Noncurrent Assets | €0 | €92.9M |
| Proceeds From Issue of Bonds Notes and Debentures | €500.0M | €0 |
| Proceeds From Noncurrent Borrowings | €90.0M | €330.0M |
| Profit Loss From Continuing Operations | €189.7M | €216.1M |
| Profit Loss From Discontinued Operations | €0 | -€35.6M |
| Purchase of Treasury Shares | €47.3M | -€2.7M |
| Repayments of Noncurrent Borrowings | €0 | €250.0M |
| Retained Earnings Excluding Profit Loss For Reporting Period | €258.2M | €300.1M |
| Retained Earnings Profit Loss For Reporting Period | €187.1M | €178.7M |
| Share of Profit Loss of Associates and Joint Ventures Accounted For Using Equity Method | €969.0K | €0 |
| Shortterm Miscellaneous Other Provisions | €29.4M | €36.9M |
| Trade and Other Current Payables To Trade Suppliers | €123.6M | €122.0M |
Methodology
Every line item above is a fact tagged in ERG SPA's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (EUR), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.